AQST 8-K 2026-08-10

Aquestive Therapeutics, Inc. (AQST) 8-K dated 2026-08-10 — accession 0001398733-26-000035. This URL is the filing, not the AQST hub.

Aquestive Therapeutics, Inc. (AQST) is a drug manufacturers - specialty & generic company listed on US.

Aquestive Therapeutics, Inc. filed a 8-K on 2026-08-10. Accession 0001398733-26-000035.

Cached items: 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported AQST revenue for 2026-06-30 was $28.3M. Net income was -$30.9M. Revenue was up 95.7% from 2026-03-31 to 2026-06-30. AQST currently screens at market cap $493.0M.

Not investment advice. The AQST SEC hub lists recent forms. The stock page is the research view.